Daojing Wang, Ph.D., Founder and President
Founded Newomics Inc. in August 2011 while a Career Scientist and Principal Investigator at LBNL, where he had worked since 2002. Since September 2013, Dr. Wang has devoted his full-time effort at Newomics to lead technology development and commercialization. Dr. Wang has been continuously serving as a principal investigator for multiple research grants and contracts from NIH, Department of Energy (DOE), National Aeronautics and Space Administration (NASA), and CBCRP at LBNL and Newomics Inc. He has published extensively in highly respected journals such as Analytical Chemistry, Cancer Research, Journal of Proteome Research, Molecular and Cellular Proteomics, Proceedings of the National Academy of Sciences, Proteomics, and Trends in Biotechnology. Dr. Wang is the co-inventor of M3 emitters and MEA chips, which together lay the foundation for the current R&D efforts at Newomics to develop application-specific platforms and solutions for precision medicine. Prior to joining LBNL, Dr. Wang had performed research at SurroMed Inc. and the University of California, San Francisco. Dr. Wang obtained his B.S. degree from University of Science and Technology of China (USTC) in 1994, Ph.D. in Chemistry from Princeton University in 1999, and completed his postdoctoral training at the University of California, Berkeley in 2000.
Pan Mao, Ph.D., Co-Founder
Co-founded Newomics Inc. with Dr. Wang in August 2011. Dr. Mao is the co-inventor of MEA chips and leads the product development of M3 emitters. Dr. Mao has extensive experience in developing micro/nanofluidic technologies to solve biological problems. He has made significant contributions to the application of micro/nanofluidics for biological sample preparation and development of fully integrated micro/nanofluidic bioanalytical systems to perform high-throughput omics analysis. Dr. Mao has published over 15 papers in well-respected journals such as Analytical Chemistry, Journal of Proteome Research, and Lab-on-a-Chip, and has served as principal investigator and co-investigator at Newomics Inc. for several NIH SBIR Phase I projects. Dr. Mao obtained his B.S. degree from USTC in 2002, Ph.D. in Mechanical Engineering from MIT in 2009, and completed his postdoctoral training at LBNL in 2013.